BCAB
Income statement / Annual
Last year (2024), BioAtla, Inc.'s total revenue was $11.00 M,
and the percentage change from the previous year is not available.
In 2024, BioAtla, Inc.'s net income was -$69.78 M.
See BioAtla, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
| Operating Revenue |
$11.00 M |
$0.00 |
$0.00 |
$250,000.00 |
$429,000.00 |
$5.20 M |
$10.63 M |
| Cost of Revenue |
$925,000.00
|
$1.22 M
|
$1.20 M
|
$1.33 M
|
$19,933.00
|
$25,919.00
|
$26.31 M
|
| Gross Profit |
$10.08 M
|
-$103.73 M
|
-$1.20 M
|
-$1.08 M
|
$409,067.00
|
$5.17 M
|
-$15.68 M
|
| Gross Profit Ratio |
0.92
|
0
|
0
|
-4.32
|
0.95
|
1
|
-1.48
|
| Research and Development Expenses |
$63.10 M
|
$103.73 M
|
$79.35 M
|
$58.27 M
|
$19.93 M
|
$25.92 M
|
$26.31 M
|
| General & Administrative Expenses |
$21.85 M
|
$25.96 M
|
$28.79 M
|
$38.42 M
|
$10.60 M
|
$7.55 M
|
$12.56 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$21.85 M
|
$25.96 M
|
$28.79 M
|
$38.42 M
|
$10.60 M
|
$7.55 M
|
$12.56 M
|
| Other Expenses |
$0.00
|
-$103.73 M
|
$10,000.00
|
$1,000.00
|
-$1,000.00
|
-$22,000.00
|
-$5,000.00
|
| Operating Expenses |
$84.94 M
|
$129.69 M
|
$108.14 M
|
$96.69 M
|
$30.53 M
|
$33.47 M
|
$38.86 M
|
| Cost And Expenses |
$84.94 M
|
$129.69 M
|
$108.14 M
|
$96.69 M
|
$30.53 M
|
$33.47 M
|
$38.86 M
|
| Interest Income |
$3.37 M
|
$6.31 M
|
$1.65 M
|
$350,000.00
|
$100,000.00
|
$128,000.00
|
$209,000.00
|
| Interest Expense |
$0.00
|
$0.00
|
$0.00
|
$3,000.00
|
$1.39 M
|
$1.63 M
|
$949,000.00
|
| Depreciation & Amortization |
$0.00
|
$1.22 M
|
$1.20 M
|
$1.33 M
|
$1.01 M
|
$860,000.00
|
$794,000.00
|
| EBITDA |
-$73.94 M |
-$122.24 M |
-$106.48 M |
-$94.07 M |
-$33.46 M |
-$27.37 M |
-$27.24 M |
| EBITDA Ratio |
-6.72
|
0
|
0
|
-376.28
|
-77.99
|
-5.26
|
-2.56
|
| Operating Income Ratio |
-6.72
|
0
|
0
|
-385.76
|
-70.16
|
-5.44
|
-2.66
|
| Total Other Income/Expenses Net |
$4.17 M
|
$6.23 M
|
$1.66 M
|
$1.04 M
|
-$5.75 M
|
-$1.59 M
|
-$745,000.00
|
| Income Before Tax |
-$69.78 M
|
-$123.46 M
|
-$106.48 M
|
-$95.40 M
|
-$35.85 M
|
-$29.86 M
|
-$28.98 M
|
| Income Before Tax Ratio |
-6.34
|
0
|
0
|
-381.61
|
-83.57
|
-5.74
|
-2.73
|
| Income Tax Expense |
$0.00
|
$0.00
|
-$1.20 M
|
$4,000.00
|
$1.39 M
|
$1.55 M
|
$204,000.00
|
| Net Income |
-$69.78 M
|
-$123.46 M
|
-$105.28 M
|
-$95.41 M
|
-$37.24 M
|
-$31.40 M
|
-$28.98 M
|
| Net Income Ratio |
-6.34
|
0
|
0
|
-381.62
|
-86.81
|
-6.04
|
-2.73
|
| EPS |
-1.44 |
-2.58 |
-2.7 |
-2.76 |
-1.11 |
-0.93 |
-1.34 |
| EPS Diluted |
-1.44 |
-2.58 |
-2.7 |
-2.76 |
-1.11 |
-0.93 |
-1.34 |
| Weighted Average Shares Out |
$48.57 M
|
$47.78 M
|
$38.93 M
|
$34.56 M
|
$33.66 M
|
$33.66 M
|
$21.59 M
|
| Weighted Average Shares Out Diluted |
$48.57 M
|
$47.78 M
|
$38.93 M
|
$34.56 M
|
$33.66 M
|
$33.66 M
|
$21.59 M
|
| Link |
|
|
|
|
|
|
|
